SOURCE: Premaitha Health PLC

July 04, 2014 02:00 ET

Premaitha Health PLC (Formerly ViaLogy PLC) ("Premaitha" or the "Company"): First Day of Dealings on AIM

Premaitha Joins AIM and Looks to Deliver Diagnostic Test Product to Improve Prenatal Screening Globally

LONDON, UNITED KINGDOM--(Marketwired - Jul 4, 2014) - Premaitha Health PLC (LSE: NIPT)

Admission to AIM

  • Premaitha's Admission and trading of its Ordinary Shares on AIM commences at 08.00hrs today (TIDM: NIPT).

  • The Company has raised £7.2 million by way of a Placing and Open Offer at a price of 11 pence per share.

  • The proceeds of the Placing and Open Offer will be used to commercialise the IONA® test and provide capital for the Enlarged Group's sales and marketing initiatives.

  • The issued share capital of the Company on Admission comprises 188,163,709 ordinary shares of 10 pence each.

Click on, or paste the following link into your web browser, to view the associated PDF document.
http://www.rns-pdf.londonstockexchange.com/rns/4400L_1-2014-7-4.pdf

This information is provided by RNS
The company news service from the London Stock Exchange

Contact Information

  • Enquiries:

    Premaitha Health plc
    David Evans
    Chairman (Non-Executive)
    Dr Stephen Little
    Chief Executive Officer
    Joanne Cross
    Marketing Communications
    Tel: +44 (0) 7736 843052
    Email: investors@premaitha.com

    Cairn Financial Advisers LLP
    Nomad
    Liam Murray
    Avi Robinson
    Tel: +44 20 7148 7900

    Panmure Gordon (UK) Limited
    Broker
    Robert Naylor
    Freddy Crossley
    Tel: +44 20 7886 2500

    TooleyStreet Communications
    Investor and media relations
    Fiona Tooley
    Tel: +44 (0) 7785 703523
    fiona@tooleystreet.com

    Instinctif Partners
    Corporate and commercial communications
    Sue Charles
    Jen Lewis
    Emma Barlow
    Tel: +44 (0) 1260 296 500
    premaitha@instinctif.com